Clinical Trials Logo

Filter by:
NCT ID: NCT06088784 Completed - Healthy Volunteers Clinical Trials

A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants

Start date: September 19, 2023
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability and pharmacokinetics of single and multiple doses of ATH-399A in healthy adults and also evaluate the effect of food on ATH-399A in order to develop mechanism-based and/or disease-modifying treatments for Parkinson Disease.

NCT ID: NCT06081166 Completed - Healthy Volunteers Clinical Trials

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

Start date: November 11, 2023
Phase: Phase 1
Study type: Interventional

A study to evaluate impact of Obicetrapib on PK levels of Atorvastatin and Rosuvastatin

NCT ID: NCT06072235 Completed - Chronic Pain Clinical Trials

Facemasks and Chronic Pain Patients With Hearing Loss

Start date: January 8, 2018
Phase:
Study type: Observational

Facemasks may impede communication. Impaired communication may worsen healthcare outcomes. This study explores the problem of hearing impairment in chronic pain patients, and the impact of facemasks on healthcare outcomes in chronic pain patients. Data collection includes patient's age, anxiety score, depression score, numeric pain score, and effects of facemasks on treatment outcomes. Pain is measured using numeric pain rating scale. Depression is measured using the Patient Health Questionnaire (PHQ-9) scale. Anxiety is measured using the General Anxiety Disorder (GAD-7) scale.

NCT ID: NCT06069011 Completed - Clinical trials for Musculoskeletal Pain

Direct Access Physiotherapy in the Pediatric Emergency Department

PedEDmsk
Start date: September 18, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare two methods of managing low acuity musculoskeletal complaints in children and adolescents ages 6 to 17.99 years in the pediatric emergency department. The main question it aims to answer is whether delivering care in two methods is feasible. Participants will receive care while in the emergency department and will be followed for a period of 1-month post-presentation.

NCT ID: NCT06057493 Completed - Healthy Clinical Trials

RDP Reliability Study

Start date: September 19, 2023
Phase:
Study type: Observational

This is an observational study designed to assess the reliability and consistency of the Optina awAIrTM CAS Test for detecting phenotypic changes in the retina that are associated with beta-amyloid status (positive or negative). The purpose of this study is to ensure that the retinal image capture process is consistent and under control, regardless of the operator or the time of measurement. The study will include enough repeated measurements on different systems, by three operators, and at different times to demonstrate.

NCT ID: NCT06048978 Completed - Glycemic Response Clinical Trials

Blood Glucose Response of Processed Starch

Start date: October 2, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to determine the postprandial glycemic response of the two starches in humans. Participants will be asked to consume 2 test foods on 2 separate occasions and provide blood glucose samples over 120 minutes postprandial.

NCT ID: NCT06046209 Completed - Myopia Clinical Trials

Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens

Start date: September 28, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to compare subjective ratings of lens handling at insertion for a monthly replacement lens versus a daily disposable lens in habitual soft lens wearers.

NCT ID: NCT06043739 Completed - Bioavailability Clinical Trials

Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects

Start date: September 22, 2023
Phase: Phase 1
Study type: Interventional

Open label study to assess relative bioavailability of filgotinib oral mini-tablet versus oral tablet formulation and effect of food on the mini-tablet formulation.

NCT ID: NCT06037148 Completed - Clinical trials for Birch Pollen Allergy

Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants

Start date: September 7, 2023
Phase: Phase 1
Study type: Interventional

Randomized, double-blind placebo-controlled phase I trial with the primary aim to investigate safety and tolerability of three ascending dosing schemes of DM-101-PX in birch pollen allergic adults. As an explorative objective, the trial will also investigate the effect of DM-101PX on the allergic symptoms following birch pollen allergen exposure in a chamber. Expanded access to the study treatment is not available.

NCT ID: NCT06035484 Completed - Healthy Clinical Trials

Effect of Seat Height and Angle on Wheelchair Foot Propulsion

Start date: April 20, 2023
Phase: N/A
Study type: Interventional

The purpose of the project is to explore the effect of differences in seat height and seat angle on bilateral foot propulsion using a manual wheelchair. The objectives of the study are to determine whether differences in seat height and seat angle impact: a) propulsion speed; b) knee range of motion used during propulsion; c) effectiveness of foot propulsion gait; and d) perceived difficulty with foot propulsion. A repeated measures designs allows comparison between 5 different seat height conditions and 4 different seat angle conditions to determine whether there are significant differences in outcome, and if so, which conditions provide better outcomes. Participants will propel a customized MWC through a standardized course using each seat configuration; the sequence will be randomized to reduce any learning effects.